Identification of novel regions of allelic loss in ependymomas by high-resolution allelotyping with 384 microsatellite markers

Journal of Neurosurgery

Volumn 95, Issue 1, 2001, Pages 9-14

  Tong, C Y K ^a   Phil, M ^a   Zheng, P P ^a   Pang, J C S ^a   Poon, W S ^a   Chang, A R ^a   Ng, H K ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Comparative genomic hybridization; Ependymoma; Loss of heterozygosity; Overlapping small deletion region

Indexed keywords

MICROSATELLITE DNA;

ADOLESCENT; ADULT; ALLELISM; ARTICLE; AUTOSOME; CARCINOGENESIS; CHROMOSOME 13; CHROMOSOME 16; CHROMOSOME 17; CHROMOSOME 19; CHROMOSOME 20; CHROMOSOME 22; CHROMOSOME DELETION; CHROMOSOME LOSS; COMPARATIVE GENOMIC HYBRIDIZATION; EPENDYMOMA; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MARKER GENE; PRIORITY JOURNAL; SCHOOL CHILD; TUMOR SUPPRESSOR GENE;

EID: 0034871190     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.2001.95.1.0009     Document Type: Article

References (39)

1. Cytogenetic analysis of 120 primary pediatric brain tumors and literature review
2. Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization
3. Molecular analysis of genetic changes in ependymomas
4. Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas
5. Infrequency of p53 gene mutations in ependymomas
6. Chromosome abnormalities in pediatric brain tumors
7. Chromosome abnormalities in low-grade central nervous system tumors
8. The molecular biology of ependymomas
9. The retinoblastomas gene is involved in malignant progression of astrocytomas
10. Clonal genomic alterations in glioma malignancy stages
11. Molecular cytogenetic studies of pediatric ependymomas
12. Identification of AF-6 and canoe as putative targets for Ras
13. LOH at 16p13 is a novel chromosomal alteration detected in benign and malignant microdissected papillary neoplasms of the breast
14. Karyotype studies in 18 ependymomas with literature review of 107 cases
15. Characterization of 20q deletions in patients with myeloproliferative disorders or myelodysplastic syndromes
16. p53 mutations in nonastrocytic human brain tumors
17. Cytogenetic and loss of heterozygosity studies in ependymomas, pilocytic astrocytomas, and oligodendrogliomas
18. Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p
19. Abnormalities of chromosome 22 in human brain tumors determined by combined cytogenetic and molecular genetic approaches
20. Chromosomal composition of a series of 22 human low-grade gliomas
21. Chromosomes in the genesis and progression of ependymomas
22. Molecular genetics of myloid leukemia: Identification of the commonly deleted segment of chromosome 20
23. Definition of a commonly deleted region in ovarian cancers to 300-kb segment of chromosome 6q27
24. Chromosome aberrations in four ependymomas
25. Hemizygous deletions of chromosome band 16q24 in Wilms tumor: Detection by fluorescence in situ hybridization
26. Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype
27. Allelic loss on chromosome 6q in primary prostate cancer
28. Loss of heterozygosity on 6q, 16q and 17p in human central nervous system primitive neuroectodermal tumors
29. Molecular genetic analysis of non-astrocytic gliomas
30. Truncating mutations of hSNF5/INI 1 in aggressive paediatric cancer
31. Allelotype of colorectal carcinomas
32. Comprehensive allelotype and genetic analysis of 466 human nervous system tumors
33. Molecular genetic analysis of chromosome arm 17p and chromosome arm 22q DNA sequences in sporadic pediatric ependymomas
34. Diversity and specialization of mammalian SWI/SNF complexes
35. Cytogenetic evidence for a chromosome 22 tumor suppressor gene in ependymoma
36. Involvement of chromosome 22 in ependymomas
37. Ependymoma
38. Comparative genomic hybridization detects losses of chromosomes 22 and 16 as the most common recurrent genetic alterations in primary ependymomas